|
1
|
Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.
|
Am J Transplant
|
2003
|
2.83
|
|
2
|
Care of the potential organ donor.
|
N Engl J Med
|
2004
|
2.66
|
|
3
|
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).
|
Am J Kidney Dis
|
2010
|
2.18
|
|
4
|
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation.
|
Transpl Int
|
2006
|
1.68
|
|
5
|
Kidney and pancreas transplantation.
|
Am J Transplant
|
2003
|
1.45
|
|
6
|
Rituximab as treatment for refractory kidney transplant rejection.
|
Am J Transplant
|
2004
|
1.42
|
|
7
|
BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction.
|
Am J Physiol Renal Physiol
|
2006
|
1.36
|
|
8
|
Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma.
|
Ann Surg
|
2002
|
1.30
|
|
9
|
Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: initial experience.
|
Radiology
|
2005
|
1.27
|
|
10
|
Functionally significant renal allograft rejection is defined by transcriptional criteria.
|
Am J Transplant
|
2005
|
1.25
|
|
11
|
Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.
|
BMC Cell Biol
|
2009
|
1.23
|
|
12
|
Campath-1H in renal transplantation: The University of Wisconsin experience.
|
Surgery
|
2004
|
1.18
|
|
13
|
Vascular access outcomes and medication use: a USRDS study.
|
Semin Dial
|
2006
|
1.15
|
|
14
|
Donation after cardiac death: the University of Wisconsin experience.
|
Ann Transplant
|
2004
|
1.14
|
|
15
|
Trends in kidney transplantation rates and disparities.
|
J Natl Med Assoc
|
2007
|
1.14
|
|
16
|
Life after transplantation: new transitions in quality of life and psychological distress.
|
Semin Dial
|
2005
|
1.11
|
|
17
|
Disease progression and outcomes in chronic kidney disease and renal transplantation.
|
Kidney Int
|
2003
|
1.10
|
|
18
|
Blood oxygen level-dependent and perfusion magnetic resonance imaging: detecting differences in oxygen bioavailability and blood flow in transplanted kidneys.
|
Magn Reson Imaging
|
2009
|
1.06
|
|
19
|
Medical care of kidney transplant recipients after the first posttransplant year.
|
Clin J Am Soc Nephrol
|
2006
|
1.05
|
|
20
|
Evaluation of eHealth web sites for patients with chronic kidney disease.
|
Am J Kidney Dis
|
2004
|
0.99
|
|
21
|
The rationale, implementation, and effect of the Medicare CKD education benefit.
|
Am J Kidney Dis
|
2011
|
0.99
|
|
22
|
In-center hemodialysis patients' use of the internet in the United States: a national survey.
|
Am J Kidney Dis
|
2006
|
0.98
|
|
23
|
Noninvasive assessment of early kidney allograft dysfunction by blood oxygen level-dependent magnetic resonance imaging.
|
Transplantation
|
2006
|
0.97
|
|
24
|
Prevention of chronic allograft nephropathy with vitamin D.
|
Transpl Int
|
2005
|
0.96
|
|
25
|
MicroRNAs in kidney function and disease.
|
Transl Res
|
2011
|
0.96
|
|
26
|
Factors affecting employment at initiation of dialysis.
|
Clin J Am Soc Nephrol
|
2011
|
0.96
|
|
27
|
Quantitative MR measures of intrarenal perfusion in the assessment of transplanted kidneys: initial experience.
|
Acad Radiol
|
2009
|
0.93
|
|
28
|
CKD stage-to-stage progression in native and transplant kidney disease.
|
Nephrol Dial Transplant
|
2007
|
0.90
|
|
29
|
Drug insight: maintenance immunosuppression in kidney transplant recipients.
|
Nat Clin Pract Nephrol
|
2006
|
0.88
|
|
30
|
Chemokines and their receptors in human renal allotransplantation.
|
Transplantation
|
2011
|
0.87
|
|
31
|
KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
|
Am J Kidney Dis
|
2008
|
0.86
|
|
32
|
Diabetic kidneys can safely expand the donor pool.
|
Transplantation
|
2002
|
0.85
|
|
33
|
"Venopathy" at work: recasting neointimal hyperplasia in a new light.
|
Transl Res
|
2010
|
0.84
|
|
34
|
Creatinine-based estimations of kidney function are unreliable in obese kidney donors.
|
J Transplant
|
2012
|
0.84
|
|
35
|
Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts.
|
Transplantation
|
2003
|
0.84
|
|
36
|
A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function.
|
Am J Nephrol
|
2002
|
0.84
|
|
37
|
A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF).
|
Ren Fail
|
2002
|
0.84
|
|
38
|
Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy.
|
Kidney Int
|
2004
|
0.84
|
|
39
|
A conflict of responsibility: no patient left behind.
|
Clin J Am Soc Nephrol
|
2010
|
0.83
|
|
40
|
Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors.
|
Am J Transplant
|
2004
|
0.83
|
|
41
|
ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro.
|
Kidney Int
|
2005
|
0.81
|
|
42
|
Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients.
|
Transplantation
|
2003
|
0.81
|
|
43
|
L-carnitine treatment of anemia.
|
Am J Kidney Dis
|
2003
|
0.80
|
|
44
|
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation.
|
Transplantation
|
2007
|
0.79
|
|
45
|
Disease progression and outcomes in type 1 diabetic kidney transplant recipients based on posttransplantation CKD staging.
|
Am J Kidney Dis
|
2007
|
0.78
|
|
46
|
Risk factors and screening for chronic kidney disease.
|
Adv Chronic Kidney Dis
|
2010
|
0.77
|
|
47
|
Intrathymic injection of anti-Fas monoclonal antibody prolongs murine non-vascularized cardiac allograft survival.
|
Transpl Int
|
2004
|
0.76
|
|
48
|
Editorial perspective. Donor kidney function - are we focusing on the trees or the forest?
|
Am J Nephrol
|
2011
|
0.75
|
|
49
|
Focusing on health literacy might help us cross the quality chasm.
|
Am J Kidney Dis
|
2009
|
0.75
|
|
50
|
Those who can do, teach.
|
Am J Kidney Dis
|
2013
|
0.75
|
|
51
|
PRACTITIONER APPLICATION.
|
J Healthc Manag
|
2016
|
0.75
|
|
52
|
The home is where the donor might be.
|
Am J Kidney Dis
|
2008
|
0.75
|
|
53
|
Another cause for the same old problem.
|
Am J Transplant
|
2004
|
0.75
|
|
54
|
AVOIDING MISSTEPS IN THE POPULATION HEALTH JOURNEY.
|
Physician Leadersh J
|
2016
|
0.75
|
|
55
|
Retrograde occlusive arteriography of hemodialysis access: failure to detect inflow lesions?
|
Semin Dial
|
2010
|
0.75
|
|
56
|
Epithelial cell polarity and improved early outcomes in delayed graft function: a pilot study of polyclonal vs monoclonal antibodies.
|
Nephrol Dial Transplant
|
2004
|
0.75
|